Dianthus Therapeutics
DNTH
DNTH
51 hedge funds and large institutions have $162M invested in Dianthus Therapeutics in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+3
Holders Change %
+6.25%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
12
Reduced
5
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
CC
Casdin Capital
New York
|
$27M |
2 |
OM
Opaleye Management
Boston,
Massachusetts
|
$8.71M |
3 |
Fidelity International
Hamilton,
Bermuda
|
$11.5M |
4 |
BlackRock
New York
|
$2.06M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
$1.74M |